Announcement on Obtaining Medical Device Registration Certificate by Holding Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Obtaining Medical Device Registration Certificate by Holding Subsidiary
Filed with SSE ·
On 6ix: 6ix.com/news/announcement-on-obtaining-medical-device-registration-certificate-by-holding-subsidiary
6ix hasn’t read this filing yet.
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jointown Pharmaceutical
- Announcement on the Results of Issuance of the 2026 Phase II Science and Technology Innovation Bonds
- Announcement on Advance Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert
- Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets
- Announcement on Completion of Industrial and Commercial Change Registration and Filing of Articles of Association
- Announcement on the Results of Issuance of the 2026 Phase I Science and Technology Innovation Bonds
Later from Jointown Pharmaceutical
- Announcement on Receipt of the "Notice of Registration Acceptance" from the National Association of Financial Market Institutional Investors
- Announcement on Temporary Idle Funds’ Investment Management Arrangements for Q1 2026
- Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Azelastine Hydrochloride Nasal Spray
- Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026
- Report for Q1 2026
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical